Company Filing History:
Years Active: 2001-2004
Title: Abdesslame Nazih: Innovator in Lipid Compounds and Gene Therapy
Introduction
Abdesslame Nazih is a notable inventor based in Strasbourg, France. He has made significant contributions to the field of lipid compounds and gene therapy, holding a total of 4 patents. His work focuses on the development of innovative compounds that facilitate the transfer of active substances into target cells.
Latest Patents
Among his latest patents, Abdesslame Nazih has developed glycerolipid compounds that are useful for the transfer of active substances into target cells. One of his notable inventions includes lipid compounds and compositions that are utilized for the transfer of polynucleotides into target cells for therapeutic purposes. These lipid compounds are characterized by a specific formula and may exist in a cationic form, often combined with biologically acceptable anions. His inventions also encompass complexes that consist of cationic lipid compounds and negatively charged active substances, along with methods of gene therapy that utilize these complexes.
Career Highlights
Throughout his career, Abdesslame Nazih has worked with various companies, including Transgene S.A. and Transgene 6.A. His expertise in lipid compounds has positioned him as a key figure in the advancement of gene therapy technologies.
Collaborations
Abdesslame Nazih has collaborated with notable professionals in his field, including Rainer Bischoff and Denis Heissler. These collaborations have further enriched his research and development efforts.
Conclusion
Abdesslame Nazih's innovative work in lipid compounds and gene therapy has made a significant impact in the scientific community. His patents reflect a commitment to advancing therapeutic methods and improving the transfer of active substances into target cells.